Associations - ERBB4 G1109C

BIOMARKER:

ERBB4 G1109C

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

ERBB4 G1109C ERBB4 G1109C	Head and Neck Cancer Head and Neck Cancer	afatinib Sensitive: D – Preclinical afatinib Sensitive : D
ERBB4 G1109C ERBB4 G1109C	Esophageal Cancer Esophageal Cancer	erlotinib Resistant: D – Preclinical erlotinib Resistant : D
ERBB4 G1109C ERBB4 G1109C	Esophageal Cancer Esophageal Cancer	cetuximab Resistant: D – Preclinical cetuximab Resistant : D
ERBB4 G1109C ERBB4 G1109C	Esophageal Cancer Esophageal Cancer	afatinib Sensitive: D – Preclinical afatinib Sensitive : D
ERBB4 G1109C ERBB4 G1109C	Squamous Cell Carcinoma of Head and Neck SCCHN	afatinib Sensitive: D – Preclinical afatinib Sensitive : D